📰 Pharmaceutical Intelligence News
Page 5 - Pharmaceutical Intelligence News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pharmaceutical Intelligence. Real-time updates on events, politics, business and more.
October 27, 2023
Buntanetap tartrate is under clinical development by Annovis Bio and currently in Phase II for Lewy Body Dementia.
October 27, 2023
ST-266 is under clinical development by Noveome Biotherapeutics and currently in Phase I for Chronic Traumatic Encephalopathy (CTE).
October 27, 2023
Epcoritamab is under clinical development by Genmab and currently in Phase II for Relapsed Chronic Lymphocytic Leukemia (CLL).
October 27, 2023
DISC-0974 is under clinical development by Disc Medicine and currently in Phase I for Myeloproliferative Disorders.
October 26, 2023
Upadacitinib ER is under clinical development by AbbVie and currently in Phase III for Alopecia Areata.
October 26, 2023
Sotigalimab is under clinical development by Pyxis Oncology and currently in Phase I for Non-Small Cell Lung Cancer.
October 26, 2023
BPRDPO-56 is under clinical development by Molecular Targeting Technologies and currently in Phase I for Solid Tumor.
October 26, 2023
ANG-003 is under clinical development by Anagram Therapeutics and currently in Phase I for Exocrine Pancreatic Insufficiency.
October 26, 2023
Anakinra is under clinical development by Swedish Orphan Biovitrum and currently in Phase II for Hospital Acquired Pneumonia (HAP).
September 14, 2023
INCA-33890 is under clinical development by Incyte and currently in Phase I for Adenocarcinoma Of The Gastroesophageal Junction.